Heat Biologics, Inc. HTBX
$ 3.93
-5.76%
Heat Biologics, Inc. Financial Ratios 2011-2024 | HTBX
Annual Financial Ratios Heat Biologics, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.3 | -0.4 | -1.6 | -0.9 | -1.4 | -1.0 | -3.1 | -3.3 | - | - |
P/S |
11.1 | 2.7 | 4.3 | 7.2 | 52.2 | - | - | - | - | - |
EV/EBITDA |
-0.9 | 0.0 | -0.2 | -0.1 | -0.8 | -1.0 | -3.0 | -3.7 | - | - |
PEG |
-0.04 | 0.01 | 0.02 | 0.02 | 0.02 | -0.03 | 0.13 | -0.04 | - | - |
P/B |
0.3 | 0.6 | 0.8 | 1.9 | 2.6 | 8.0 | 3.4 | 1.3 | - | - |
P/CF |
-1.5 | -0.6 | -1.1 | -1.7 | -1.3 | -1.1 | -3.6 | -4.4 | - | - |
ROE % |
-22.56 | -152.13 | -52.02 | -204.84 | -183.83 | -813.43 | -106.87 | -40.11 | - | - |
ROA % |
-20.97 | -77.12 | -41.66 | -58.65 | -141.33 | -153.54 | -74.07 | -37.84 | - | - |
ROCE % |
-20.73 | -110.70 | -53.10 | -133.14 | -179.79 | -335.98 | -91.32 | -30.06 | - | - |
DSO |
21.9 | 4.2 | 1.8 | 3.6 | 87.9 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - |
All numbers in USD currency